dc.contributor.author | Dunn, BD | |
dc.contributor.author | German, RE | |
dc.contributor.author | Khazanov, G | |
dc.contributor.author | Xu, C | |
dc.contributor.author | Hollon, SD | |
dc.contributor.author | DuRubeis, RJ | |
dc.date.accessioned | 2019-06-10T13:50:21Z | |
dc.date.issued | 2019-11-07 | |
dc.description.abstract | The cardinal symptoms of Major Depressive Disorder (MDD) are heightened depressed
mood (negative affectivity; NA) and diminished interest or pleasure (positive affectivity;
PA). It is unknown how well treatments for MDD repair each. Two secondary analyses of
randomized controlled trials were therefore conducted. In Study One, 180 adult depressed
outpatients received sixteen-weeks of antidepressant medication (ADM; n=120) or Cognitive
Therapy (CT; n=60). In Study Two, adult depressed outpatients were treated until remission
with ADM (n=225) or ADM and CT (n=227). Across trials and treatments, intake
disturbances were more marked in PA than NA, there was smaller repair of PA than NA
during treatment, and disturbances remained more pronounced for PA than NA posttreatment. Greater change in PA and NA were independently associated with depression
symptom change. These findings suggest depression treatments more effectively repair NA
than PA and that outcomes may be improved with more effective targeting of the latter. | en_GB |
dc.description.sponsorship | National Institute of Mental Health | en_GB |
dc.identifier.citation | Vol. 8 (1), pp. 36 - 51 | en_GB |
dc.identifier.doi | 10.1177/2167702619863427 | |
dc.identifier.grantnumber | MH55877 | |
dc.identifier.grantnumber | MH555875 | |
dc.identifier.grantnumber | MH60713 | |
dc.identifier.grantnumber | K02-MH01697 | |
dc.identifier.grantnumber | MH60998 | |
dc.identifier.grantnumber | MH060768 | |
dc.identifier.uri | http://hdl.handle.net/10871/37436 | |
dc.language.iso | en | en_GB |
dc.publisher | SAGE Publications | en_GB |
dc.title | Changes in positive and negative affect during pharmacological treatment and cognitive therapy for major depressive disorder - A secondary analysis of two randomized controlled trials | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-06-10T13:50:21Z | |
dc.identifier.issn | 2167-7026 | |
dc.description | This is the author accepted manuscript | en_GB |
dc.identifier.journal | Clinical Psychological Science | en_GB |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
dcterms.dateAccepted | 2019-06-06 | |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2019-06-06 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-06-10T13:39:45Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2019-11-05T16:22:32Z | |
refterms.panel | A | en_GB |